Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Pasadena, CA
SEC filing record 1 source field available
Fiscal year end
30 September
ARROWHEAD PHARMACEUTICALS, INC. has filed 1,338 SEC EDGAR filings since 02 Jan 1998

SEC filing history

Showing 976-995 of 995 matching filings.

Per page
25
Current page
40
DEFA14A File 000-21898

DEFINITIVE ADDITIONAL MATERIALS

Filing date
30 Apr 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 000-21898

DEFINITIVE PROXY STATEMENT

Filing date
30 Apr 2010
Reporting date
16 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
27 Apr 2010
Reporting date
21 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
19 Apr 2010
Reporting date
14 Apr 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
3

STOCK OPTION GRANT

Filing date
15 Apr 2010
Reporting date
16 Nov 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
23 Mar 2010
Reporting date
22 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
19 Mar 2010
Reporting date
16 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

R.B. STEWART STOCK OPTION GRANT 3/2010

Filing date
08 Mar 2010
Reporting date
04 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

C. MCKENNEY STOCK OPTION GRANT 3/2010

Filing date
08 Mar 2010
Reporting date
04 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

L. RAHN STOCK OPTION GRANT 03/2010

Filing date
08 Mar 2010
Reporting date
04 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

E. FRYKMAN STOCK OPTION GRANT 03/04/2010

Filing date
08 Mar 2010
Reporting date
04 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

C. ANZALONE STOCK OPTION GRANT 03/2010

Filing date
08 Mar 2010
Reporting date
04 Mar 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-21898

FORM 10-Q

Filing date
11 Feb 2010
Reporting date
31 Dec 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
11 Feb 2010
Reporting date
11 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
04 Feb 2010
Reporting date
01 Feb 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-87940-7D

D filing

Filing date
29 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-164039

PROSPECTUS

Filing date
12 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-161344

PROSPECTUS

Filing date
12 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-164039

EFFECT filing

Filing date
07 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-161344

EFFECT filing

Filing date
07 Jan 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .